Ferulic acid alleviates changes in a rat model of metabolic syndrome induced by high-carbohydrate, high-fat diet

Nutrients

Volumn 7, Issue 8, 2015, Pages 6446-6464

  Senaphan, Ketmanee ^a   Kukongviriyapan, Upa ^a   Sangartit, Weerapon ^a   Pakdeechote, Poungrat ^a   Pannangpetch, Patchareewan ^a   Prachaney, Parichat ^a   Greenwald, Stephen E ^b   Kukongviriyapan, Veerapol ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Endothelial dysfunction; Ferulic acid; High carbohydrate high fat diet; Inflammation; Metabolic syndrome; Oxidative stress; Vascular remodeling

Indexed keywords

ACETYLCHOLINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FERULIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; PROPYLENE GLYCOL; TUMOR NECROSIS FACTOR ALPHA; CARBOHYDRATE DIET; COUMARIC ACID; FRUCTOSE; GLUCOSE BLOOD LEVEL; NOS3 PROTEIN, RAT; TUMOR NECROSIS FACTOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FLOWMETRY; BLOOD VESSEL REACTIVITY; CARBOHYDRATE DIET; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE BLOOD LEVEL; HISTOLOGY; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; LIPID DIET; MALE; METABOLIC SYNDROME X; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; SYSTOLIC BLOOD PRESSURE; UPREGULATION; VASCULAR REMODELING; WESTERN BLOTTING; ADMINISTRATION AND DOSAGE; ADVERSE EFFECTS; ANIMAL; BLOOD; BLOOD PRESSURE; BODY WEIGHT; DISEASE MODEL; DRUG EFFECTS; GENETICS; GLUCOSE TOLERANCE TEST; METABOLISM; ORGAN SIZE; SPRAGUE DAWLEY RAT;

ANIMALS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY WEIGHT; COUMARIC ACIDS; DIET, HIGH-FAT; DIETARY CARBOHYDRATES; DISEASE MODELS, ANIMAL; DOWN-REGULATION; FRUCTOSE; GLUCOSE TOLERANCE TEST; MALE; MALONDIALDEHYDE; METABOLIC SYNDROME X; NITRIC OXIDE SYNTHASE TYPE III; ORGAN SIZE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84940864919     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu7085283     Document Type: Article

References (37)

1. Williamson, G.; Manach, C. Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am. J. Clin. Nutr. 2005, 81, 243S-255S. [PubMed]
2. Tsao, R. Chemistry and biochemistry of dietary polyphenols. Nutrients 2010, 2, 1231-1246. [CrossRef] [PubMed]
3. Manach, C.; Scalbert, A.; Morand, C.; Remesy, C.; Jimenez, L. Polyphenols: Food sources and bioavailability. Am. J. Clin. Nutr. 2004, 79, 727-747. [PubMed]
4. Prakash, D.; Upadhyay, G.; Pushpangadan, P.; Gupta, C. Antioxidant and free radical scavenging activities of some fruits. J. Complement Integr. Med. 2011, 8. [CrossRef] [PubMed]
5. Zhao, Z.; Moghadasian, M.H. Chemistry, natural sources, dietary intake and pharmacokinetic properties of ferulic acid: A review. Food Chemistry 2008, 109, 691-702. [CrossRef] [PubMed]
6. Bourne, L.; Paganga, G.; Baxter, D.; Hughes, P.; Rice-Evans, C. Absorption of ferulic acid from low-alcohol beer. Free Radic. Res. 2000, 32, 273-280. [CrossRef] [PubMed]
7. Mancuso, C.; Santangelo, R. Ferulic acid: Pharmacological and toxicological aspects. Food Chem. Toxicol. 2014, 65, 185-195. [CrossRef] [PubMed]
8. Ohsaki, Y.; Shirakawa, H.; Koseki, T.; Komai, M. Novel effects of a single administration of ferulic acid on the regulation of blood pressure and the hepatic lipid metabolic profile in stroke-prone spontaneously hypertensive rats. J. Agric. Food Chem. 2008, 56, 2825-2830.
9. Suzuki, A.; Yamamoto, M.; Jokura, H.; Fujii, A.; Tokimitsu, I.; Hase, T.; Saito, I. Ferulic acid restores endothelium-dependent vasodilation in aortas of spontaneously hypertensive rats. Am. J. Hypertens. 2007, 20, 508-513. [CrossRef] [PubMed]
10. Wang, B.; Ouyang, J.; Liu, Y.; Yang, J.; Wei, L.; Li, K.; Yang, H. Sodium ferulate inhibits atherosclerogenesis in hyperlipidemia rabbits. J. Cardiovasc. Pharmacol. 2004, 43, 549-554. [CrossRef] [PubMed]
11. Jung, E.H.; Kim, S.R.; Hwang, I.K.; Ha, T.Y. Hypoglycemic effects of a phenolic acid fraction of rice bran and ferulic acid in C57BL/KsJ-db/db mice. J. Agric. Food Chem. 2007, 55, 9800-9804. [CrossRef] [PubMed]
12. Sri Balasubashini, M.; Rukkumani, R.; Menon, V.P. Protective effects of ferulic acid on hyperlipidemic diabetic rats. Acta Diabetol. 2003, 40, 118-122.
13. Son, M.J.; Rico, C.W.; Nam, S.H.; Kang, M.Y. Influence of oryzanol and ferulic Acid on the lipid metabolism and antioxidative status in high fat-fed mice. J. Clin. Biochem. Nutr. 2010, 46, 150-156.
14. Ou, L.; Kong, L.Y.; Zhang, X.M.; Niwa, M. Oxidation of ferulic acid by Momordica charantia peroxidase and related anti-inflammation activity changes. Biol. Pharm. Bull. 2003, 26, 1511-1516. [CrossRef] [PubMed]
15. Bonadonna, R.; Cucinotta, D.; Fedele, D.; Riccardi, G.; Tiengo, A. The metabolic syndrome is a risk indicator of microvascular and macrovascular complications in diabetes: Results from Metascreen, a multicenter diabetes clinic-based survey. Diabetes Care. 2006, 29, 2701-2707. [PubMed]
16. Gupta, N.; Goel, K.; Shah, P.; Misra, A. Childhood obesity in developing countries: Epidemiology, determinants, and prevention. Endocr. Rev. 2012, 33, 48-70. [CrossRef] [PubMed]
17. Panchal, S.K.; Poudyal, H.; Iyer, A.; Nazer, R.; Alam, M.A.; Diwan, V.; Kauter, K.; Sernia, C.; Campbell, F.; Ward, L.; et al. High-carbohydrate, high-fat diet-induced metabolic syndrome and cardiovascular remodeling in rats. J. Cardiovasc. Pharmacol. 2011, 57, 611-624. [CrossRef] [PubMed]
18. Aydin, S.; Aksoy, A.; Kalayci, M.; Yilmaz, M.; Kuloglu, T.; Citil, C.; Catak, Z. Today's and yesterday's of pathophysiology: biochemistry of metabolic syndrome and animal models. Nutrition 2014, 30, 1-9. [CrossRef] [PubMed]
19. Kennedy, A.J.; Ellacott, K.L.; King, V.L.; Hasty, A.H. Mouse models of the metabolic syndrome. Dis. Model Mech. 2010, 3, 156-166. [CrossRef] [PubMed]
20. Panchal, S.K.; Brown, L. Rodent models for metabolic syndrome research. J. Biomed. Biotechnol. 2011, 2011, 351982. [CrossRef] [PubMed]
21. Nascimento, A.R.; Machado, M.; de Jesus, N.; Gomes, F.; Lessa, M.A.; Bonomo, I.T.; Tibirica, E. Structural and functional microvascular alterations in a rat model of metabolic syndrome induced by a high-fat diet. Obesity 2013, 21, 2046-2054. [CrossRef] [PubMed]
22. Roberts, C.K.; Barnard, R.J.; Sindhu, R.K.; Jurczak, M.; Ehdaie, A.; Vaziri, N.D. A high-fat, refined-carbohydrate diet induces endothelial dysfunction and oxidant/antioxidant imbalance and depresses NOS protein expression. J. Appl. Physiol. 2005, 98, 203-210. [CrossRef] [PubMed]
23. Allain, C.C.; Poon, L.S.; Chan, C.S.; Richmond, W.; Fu, P.C. Enzymatic determination of total serum cholesterol. Clin. Chem. 1974, 20, 470-475. [PubMed]
24. Matthews, D.R.; Hosker, J.P.; Rudenski, A.S.; Naylor, B.A.; Treacher, D.F.; Turner, R.C. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28, 412-419. [CrossRef] [PubMed]
25. Boonla, O.; Kukongviriyapan, U.; Pakdeechote, P.; Kukongviriyapan, V.; Pannangpetch, P.; Prachaney, P.; Greenwald, S.E. Curcumin improves endothelial dysfunction and vascular remodeling in 2K-1C hypertensive rats by raising nitric oxide availability and reducing oxidative stress. Nitric Oxide 2014, 42, 44-53. [CrossRef] [PubMed]
26. Nakmareong, S.; Kukongviriyapan, U.; Pakdeechote, P.; Donpunha, W.; Kukongviriyapan, V.; Kongyingyoes, B.; Sompamit, K.; Phisalaphong, C. Antioxidant and vascular protective effects of curcumin and tetrahydrocurcumin in rats with L-NAME-induced hypertension. Naunyn Schmiedebergs Arch. Pharmacol. 2011, 383, 519-529. [CrossRef] [PubMed]
27. Luangaram, S.; Kukongviriyapan, U.; Pakdeechote, P.; Kukongviriyapan, V.; Pannangpetch, P. Protective effects of quercetin against phenylhydrazine-induced vascular dysfunction and oxidative stress in rats. Food Chem. Toxicol. 2007, 45, 448-455. [CrossRef] [PubMed]
28. Nakmareong, S.; Kukongviriyapan, U.; Pakdeechote, P.; Kukongviriyapan, V.; Kongyingyoes, B.; Donpunha, W.; Prachaney, P.; Phisalaphong, C. Tetrahydrocurcumin alleviates hypertension, aortic stiffening and oxidative stress in rats with nitric oxide deficiency. Hypertens. Res. 2012, 35, 418-425. [CrossRef] [PubMed]
29. Cai, H.; Harrison, D.G. Endothelial dysfunction in cardiovascular diseases: The role of oxidant stress. Circ. Res. 2000, 87, 840-844. [CrossRef] [PubMed]
30. Alam, M.A.; Kauter, K.; Brown, L. Naringin improves diet-induced cardiovascular dysfunction and obesity in high carbohydrate, high fat diet-fed rats. Nutrients 2013, 5, 637-650. [CrossRef] [PubMed]
31. Rotter, V.; Nagaev, I.; Smith, U. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-α, overexpressed in human fat cells from insulin-resistant subjects. J. Biol. Chem. 2003, 278, 45777-45784. [CrossRef] [PubMed]
32. Boonloh, K.; Kukongviriyapan, U.; Pannangpetch, P.; Kongyingyoes, B.; Senggunprai, L.; Prawan, A.; Thawornchinsombut, S.; Kukongviriyapan, V. Rice bran protein hydrolysates prevented interleukin-6- and high glucose-induced insulin resistance in HepG2 cells. Food Funct. 2015, 6, 566-573. [CrossRef] [PubMed]
33. Otani, H. Oxidative stress as pathogenesis of cardiovascular risk associated with metabolic syndrome. Antioxid. Redox Signal. 2011, 15, 1911-1926. [CrossRef] [PubMed]
34. Cooper-DeHoff, R.M.; Gong, Y.; Handberg, E.M.; Bavry, A.A.; Denardo, S.J.; Bakris, G.L.; Pepine, C.J. Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. JAMA 2010, 304, 61-68. [CrossRef] [PubMed]
35. Chatzizisis, Y.S.; Coskun, A.U.; Jonas, M.; Edelman, E.R.; Feldman, C.L.; Stone, P.H. Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: Molecular, cellular, and vascular behavior. J. Am. Coll. Cardiol. 2007, 49, 2379-2393. [CrossRef] [PubMed]
36. Alam, M.A.; Sernia, C.; Brown, L. Ferulic acid improves cardiovascular and kidney structure and function in hypertensive rats. J. Cardiovasc. Pharmacol. 2013, 61, 240-249. [CrossRef] [PubMed]
37. Rodrigo, R.; Gonzalez, J.; Paoletto, F. The role of oxidative stress in the pathophysiology of hypertension. Hypertens. Res. 2011, 34, 431-440. [CrossRef] [PubMed]